Biosimilars and Bioavailability

Pharmacokinetics: Study of pharmacology concerned with movement of drugs within the body.
Biopharmaceutics: The study of the chemical and physical properties of drugs and the biological effects they produce.
Bioequivalence: Division of pharmacokinetics to assess the biological equivalence of two proprietary preparations of a drug.
Absolute and Relative Bioavailability: Absolute bioavailability is determined by comparing the blood (plasma) concentration-time-curves with drug usage. Relative bioavailability is determined by comparing the plasma concentration-time-curves with different formulations of drug usage.
Bioanalytical Methods &Bioequivalence Studies: Combined platform to evaluate the analytical methods on bioequivalence.
Drug Clinical Studies: Safety and efficacy studies of the drug on human participants.
Clinical and Experimental Pharmacology: Clinical pharmacology is the study of drugs and their clinical use. Experimental pharmacology is study through experimental use in controlled situations.
Biochemistry &Pharmacology: The interlinking of biochemical processes with drugs and study the combined effect.
Pharmaceutical Research: Research analysis on everyday pharmaceutical products and studies.
Pharmaceutical Science and Research: Research analysis on developments in pharmaceutical science.
Pharmaceutical Regulatory Affairs: Governments? approach to protect public health by controlling the safety and efficacy of pharmaceutical products.
Drug BA/BE studies: Bioavailability and Bioequivalence studies of pharmaceutical drugs.
Bioequivalence and Simulation: Imitation of biological equivalence of two proprietary preparations of a drug.
Biosimilars Requirement: To deal with need of bioequivalence in the field of Pharma.
Biowaivers: Bioavailability and/or bioequivalence studies that can be waived are called biowaivers.
Bioavailability Enhancement: Enriching the studies and methods in bioavailability.
Drug Delivery Systems: Drug delivery refers to approaches for transporting a pharmaceutical compound in the body.
Drug Delivery Pathway: The means and ways for drug transport in the body.
BiosimilarsOncology: Role of biosimilars in cancer
Biosimilars-Regulatory Affairs: Governments? approach toprotect public health by controlling the safety and efficacy of biosimilars.
Biosimilars and Pharmacology: Action mechanism of biosimilars.
Drug Development Systems: Development of drug upon drug delivery tests and preparation of systems to handle the process.
Bioavailability: The proportion of a drug in body circulation to have an active effect.
Biosimilars Models: A biopharmaceutical drug designed to have active properties similar to already licensed drug.
General Bioequivalence: Study of all general aspects of bioequivalence.
Bioavailability Metrics: Methods to measure and produce statistical data in terms of advancement of bioavailability.

All submissions will undergo vigorous peer review process.
High quality review process.
Permanent published archives.
Author loyal benefits.
Reviewer credits.
Visible specified citations.
Open access - Maximum dissemination.
Un-interrupted author communication.
Standard author guidelines.
Minimal publication charges with convenient and safe modes of transfer.

No articles available in Current Issue

No articles available in Previous Issue

Issues and Volumes: 2021

Volume 5, Issue 1

Volume 1, Issue 1

Enliven: Biosimilars and Bioavailability

Issues and Volumes: 2021

Ho Wai Loon Calvin

Jagat Kanwar

Shankar Lanke

Yasser Bustanji